Skip to main content

Advertisement

Figure 1 | BMC Cancer

Figure 1

From: Laparoscopy to predict the result of primary cytoreductive surgery in advanced ovarian cancer patients (LapOvCa-trial): a multicentre randomized controlled study

Figure 1

LapOvCa-trial design. * = Physical examination, ultrasound, tumor markers, chest X-ray, abdominal CT. # = Largest residual tumor localization, left behind at the end of cytoreductive surgery, is more than 1 cm in diameter. •Debulking surgery feasible: residual tumor after surgery will be < 1 cm. •Debulking surgery not feasible: residual tumor after surgery will be > 1 cm.

Back to article page